IL-12 Influence mTOR to Modulate CD8+ T Cells Differentiation through T-bet and Eomesodermin in Response to Invasive

Hao Wang1, Jingdong Li2, Qiyang Han3

  • 1Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Science, Beijing, China.

Insights

Interleukin-12 (IL-12) activates the mTOR pathway to promote CD8+ T cell differentiation and enhance immune responses against invasive pulmonary aspergillosis (IPA). Blocking mTOR impairs these beneficial effects.

Area of Science:

  • Immunology
  • Cellular Biology
  • Infectious Diseases

Background:

  • CD8+ T cells are crucial for adaptive immunity against fungal infections.
  • The mechanistic target of rapamycin (mTOR) signaling pathway regulates T cell proliferation and differentiation.
  • Invasive pulmonary aspergillosis (IPA) is a serious fungal infection with significant mortality.

Purpose of the Study:

  • To investigate if the mTOR pathway regulates CD8+ T cell proliferation and differentiation via T-bet and Eomes.
  • To explore the role of Interleukin-12 (IL-12) in this process during IPA.

Main Methods:

  • Established an IPA mouse model using Aspergillus fumigatus.
  • Treated mice with rapamycin (mTOR inhibitor) or IL-12.
  • Analyzed CD8+ T cell effector memory (Tem) numbers, cytokine production (IFN-γ, IL-6, IL-10), and transcription factor expression (T-bet, Eomes) using flow cytometry and ELISA.

Main Results:

  • IL-12 treatment increased CD8+ Tem numbers and IFN-γ expression, while rapamycin treatment decreased them.
  • IL-12 upregulated mTOR, S6K, and IFN-γ, promoting T-bet and downregulating Eomes for Tem differentiation.
  • IL-12 enhanced host immune response by increasing IL-6 and decreasing IL-10 levels.

Conclusions:

  • IL-12 activates the mTOR signaling pathway to promote CD8+ Tem cell differentiation and function.
  • This IL-12-mediated mTOR activation enhances immune regulation against IPA.
  • CD8+ Tem cell activity significantly impacts host immune response in IPA.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
2.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K